ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,805Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 780

$1.52M Total Retail Price of All Prescriptions

Rank: 13 out of 780

1,062 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,062 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 1,062 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 24,471 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,487 863 S3 1 1
OMEPRAZOLE 1,454 1,068 2 3
AMLODIPINE BESYLATE 1,162 877 3 4
SIMVASTATIN 1,116 956 4 2
LISINOPRIL 1,068 823 5 6
FUROSEMIDE 942 747 6 7
LEVOTHYROXINE SODIUM 932 759 7 5
MELOXICAM 847 595 8 16
TRAMADOL HCL 833 696 9 15
TRIAMTERENE-HCTZ 741 528 10 10 37
BISOPROLOL-HYDROCHLOROTHIAZIDE 659 482 10 11 95
WARFARIN SODIUM 574 471 12 24
CITALOPRAM HBR 561 403 13 23
ATORVASTATIN CALCIUM 492 378 14 12
LOSARTAN POTASSIUM 484 365 15 18
METFORMIN HCL ER 467 359 16 43
CARVEDILOL 456 304 17 14
KLOR-CON M20 433 327 18 57
METOPROLOL SUCCINATE 421 315 19 20
HYDRALAZINE HCL 421 359 19 54
GLIMEPIRIDE 399 308 21 30
NEXIUM 389 250 22 22
MIRTAZAPINE 389 345 22 58
ZOLPIDEM TARTRATE 369 237 24 17
POTASSIUM CHLORIDE 368 266 25 11
PANTOPRAZOLE SODIUM 354 240 26 25
BISOPROLOL FUMARATE 339 269 27 143
AMLODIPINE BESYLATE-BENAZEPRIL 332 209 28 50
CRESTOR 324 264 29 32
GABAPENTIN 324 213 29 13
METFORMIN HCL 313 234 31 8
NIFEDIPINE ER 305 280 32 115
LEVOFLOXACIN 301 228 33 76
PRAVASTATIN SODIUM 287 225 34 9
IBUPROFEN 286 219 35 93
DIOVAN 252 211 36 55
METOPROLOL TARTRATE 248 215 37 19
TAMSULOSIN HCL 246 224 38 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 227 217 39 26
ALLOPURINOL 224 147 40 29
LACTULOSE 190 141 41 178
ISOSORBIDE MONONITRATE ER 183 157 42 60
JANUVIA 182 144 43 85
CLOTRIMAZOLE-BETAMETHASONE 180 129 44 166
HYDROCHLOROTHIAZIDE 176 120 45 10
NIASPAN 160 120 46 167
CLONIDINE HCL 159 94 47 28
PROBENECID-COLCHICINE 157 118 10 48 314
ZETIA 151 118 49 94
DONEPEZIL HCL 149 149 50 31
CLOPIDOGREL 146 116 51 34
NIFEDICAL XL 146 140 51 209
AMOX TR-POTASSIUM CLAVULANATE 127 86 53 135
ALENDRONATE SODIUM 125 100 54 44
LOVASTATIN 118 108 55 47
INSULIN SYRINGE 116 74 56 80
CYCLOBENZAPRINE HCL 115 52 R 57 42
ADVAIR DISKUS 114 86 58 68
ESCITALOPRAM OXALATE 112 83 59 61
AZITHROMYCIN 109 62 60 38
DIGOXIN 104 67 61 56
TRAZODONE HCL 104 79 61 35
FLUTICASONE PROPIONATE 103 60 63 41
PLAVIX 101 82 64 45
BUPROPION HCL SR 100 74 65 193
GLIPIZIDE ER 100 85 65 109
EXFORGE 98 75 67 196
COLCRYS 97 73 68 131
PEN NEEDLE 96 50 69 136
POLYETHYLENE GLYCOL 3350 95 66 70 79
PROMETHAZINE HCL 95 39 R 70 66
CIPROFLOXACIN HCL 94 67 72 49
SPIRONOLACTONE 94 53 72 53
SERTRALINE HCL 94 47 72 27
VENTOLIN HFA 93 49 75 91
NAMENDA 90 90 76 46
AMIODARONE HCL 88 81 77 139
PROAIR HFA 87 37 78 62
LOSARTAN-HYDROCHLOROTHIAZIDE 82 61 79 33
CELEBREX 81 53 80 89
KLOR-CON M10 81 69 80 168
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 50 82 88
LYRICA 75 57 83 52
NOVOLOG 72 41 84 158
OXYBUTYNIN CHLORIDE ER 72 67 84 169
CLONIDINE 71 37 86 363
MECLIZINE HCL 71 65 86 83
GLYBURIDE-METFORMIN HCL 69 69 R 88 108
HUMULIN 70-30 68 50 89 106
METOLAZONE 67 47 90 195
SINGULAIR 63 35 91 73
TRIAMTERENE-HYDROCHLOROTHIAZID 62 34 92 162
PAROXETINE HCL 61 44 93 69
HUMALOG MIX 75-25 60 58 94 243
MUPIROCIN 60 45 94 173
LANTUS 59 32 96 71
RAMIPRIL 59 25 96 70
DILTIAZEM ER 59 58 96 134
BENICAR 59 48 96 207
ATENOLOL 57 36 100 21
PHENYTOIN SODIUM EXTENDED 56 32 101 128
HYDROXYZINE HCL 54 32 R 102 155
LEVEMIR 52 27 103 198
LEVETIRACETAM 51 39 104 130
VESICARE 50 35 105 186
SPIRIVA 50 44 105 72
METHYLPREDNISOLONE 50 36 105 92
DIOVAN HCT 50 40 105 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.